Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Meeting of the Board of Directors of Jagsonpal Pharmaceuticals Limited ('the Company') is scheduled to be held on Friday, November 03, 2023 to consider and approve, inter-alia, the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023
26-10-2023
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In Compliance with Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 we are enclosing herewith a copy of the certificate received from M/s MCS Share Transfer Agent Limited, the Registrar and Share Transfer Agent of the Company, for the quarter ended September 30, 2023.
05-10-2023
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Closure of Trading Window

In terms of SEBI (Prohibition of Insider Trading) Regulation, 2015 and Company''s Code of Conduct to regulate, monitor and report trading by designated persons & immediate relatives of designation persons, the Trading Window for dealing in securities of Jagsonpal Pharmaceuticals Limited (" the Company") shall remain closed for Designated Persons and their Immediate relative(s) with effect from Sunday, October 01, 2023 till the end of 48 hours after the declaration of Unaudited Financial Result for quarter and half year ended September 30, 2023.
29-09-2023
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Clarification sought from Jagsonpal Pharmaceuticals Ltd

The Exchange has sought clarification from Jagsonpal Pharmaceuticals Ltd on September 13, 2023, with reference to Movement in Volume.The reply is awaited.
13-09-2023
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 please find enclosed herewith Voting results of the 44th AGM held on Thursday, August 31, 2023 through Video Conferencing/Other Audio Visual Means (''VC/OAVM'') along with Scrutinizer Report dated August 31, 2023 pursuant to Companies Act, 2013 and Rules made thereunder.
01-09-2023
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 (''Listing Regulations'') read with Para A of Part A of Schedule III of the Listing Regulations, Please find enclosed herewith summary of proceedings of the 44th AGM of the Company held on Thursday, August 31, 2023 at 3:30 P.M. (IST), through Video Conference (''VC'')/ Other Audio Visual Means (''OAVM''). The detailed results of e-Voting (both for remote e-Voting and Voting at AGM) along with Scrutinizer report shall be intimated separately.
01-09-2023
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication

In terms of Regulation 30 of SEBI (LODR) Regulations, 2015 please find enclosed copies of the newspaper advertisement for 44th AGM of the Company to be held through Video Conferencing (VC)/other audio visual means on August 31, 2023.
10-08-2023
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Notice Of The 44Th Annual General Meeting And Annual Report For The FY 2022-23

Pursuant to Regulation 30 and 34 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 ("Listing Regulations"), please find enclosed the Annual Report and Notice convening the 44th Annual General Meeting of the Company for financial year 2022-23 is scheduled to be held on Thursday, August 31, 2023 at 03:30 p.m. through video conference or other audio visual means.
09-08-2023
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Business Responsibility and Sustainability Reporting (BRSR)

Pursuant to Regulation 34(2)(f) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed Business Responsibility and Sustainability Report (''BRSR'') for the financial year 2022-23 which forms as part of the Annual Report for the financial year 2022-23.
09-08-2023
Next Page
Close

Let's Open Free Demat Account